Coronavirus vaccines for children aged five to 12 will have to clear two approval hurdles when Pfizer lodges an application.
The pharmaceutical giant is expected to apply for its vaccine to be used in younger children following a similar move in the US.
The Therapeutic Goods Administration gives safety and efficacy approval, while the Australian Technical Advisory Group on Immunisation make recommendations about use.
Pfizer is expected to apply for its vaccine to be used in children aged five to 12, but will need to clear two approval hurdles (Pictured: Lydia, 7, receiving the Pfizer vaccine during a trial in North Carolina, USA)
Health Minister Greg Hunt said Australia had secured enough doses to vaccinate five to 12-year-olds if approval was granted.
'Our approach has always been that we see this as a double green light,' Mr Hunt told reporters on Tuesday.
But he refused to speculate about the potential of clashing TGA and ATAGI advice after similar agencies in the US split on booster shots for certain groups of adults.
'I'm very confident they have aligned their advice right throughout the pandemic and I would expect that would continue,' the health minister said.
Health Minister Greg Hunt (pictured) said Australia had secured enough doses to vaccinate five to 12-year-olds if approval was granted
ATAGI is expected to release recommendations about booster shots for the wider population in coming weeks after backing third jabs for immunocompromised people.
Australia's vaccination rollout continues to motor ahead after a sluggish start, with more than two million doses administered in the past week.
Despite fears jab rates may taper off, the program is maintaining pace with almost 83 per cent of over-16s having received at least one dose.
Despite fears jab rates may taper off, the program is maintaining pace with almost 83
